Edward Havranek
Concepts (461)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 51 | 2018 | 2145 | 2.380 |
Why?
| Hypertension | 20 | 2022 | 1235 | 2.190 |
Why?
| Antihypertensive Agents | 9 | 2021 | 485 | 1.880 |
Why?
| Text Messaging | 5 | 2020 | 149 | 1.700 |
Why?
| Medication Adherence | 9 | 2022 | 560 | 1.650 |
Why?
| Healthcare Disparities | 8 | 2023 | 579 | 1.450 |
Why?
| Socioeconomic Factors | 11 | 2021 | 1212 | 1.200 |
Why?
| Heart Diseases | 3 | 2019 | 345 | 1.160 |
Why?
| Social Values | 2 | 2021 | 34 | 1.150 |
Why?
| Out-of-Hospital Cardiac Arrest | 4 | 2024 | 70 | 1.100 |
Why?
| Racism | 3 | 2021 | 129 | 1.070 |
Why?
| Health Status | 12 | 2018 | 755 | 1.040 |
Why?
| Myocardial Infarction | 17 | 2015 | 1015 | 0.950 |
Why?
| Blood Pressure | 9 | 2016 | 1728 | 0.910 |
Why?
| Weight Loss | 5 | 2018 | 725 | 0.900 |
Why?
| Cardiovascular Diseases | 11 | 2019 | 1999 | 0.860 |
Why?
| Social Determinants of Health | 2 | 2018 | 220 | 0.860 |
Why?
| Hospitalization | 24 | 2020 | 2057 | 0.860 |
Why?
| Prediabetic State | 2 | 2016 | 245 | 0.830 |
Why?
| Patient Satisfaction | 6 | 2019 | 641 | 0.810 |
Why?
| Resuscitation Orders | 2 | 2020 | 46 | 0.770 |
Why?
| Attitude to Health | 2 | 2021 | 431 | 0.770 |
Why?
| Hypertrophy, Left Ventricular | 3 | 2008 | 126 | 0.760 |
Why?
| Health Services Accessibility | 2 | 2019 | 896 | 0.750 |
Why?
| Sexual Health | 2 | 2020 | 54 | 0.750 |
Why?
| Aged | 79 | 2021 | 21953 | 0.740 |
Why?
| Humans | 143 | 2024 | 128417 | 0.730 |
Why?
| Physician-Patient Relations | 5 | 2013 | 535 | 0.710 |
Why?
| Sexually Transmitted Diseases | 2 | 2020 | 150 | 0.710 |
Why?
| Middle Aged | 60 | 2022 | 30889 | 0.690 |
Why?
| Health Status Disparities | 3 | 2021 | 254 | 0.680 |
Why?
| Male | 100 | 2024 | 62857 | 0.670 |
Why?
| Female | 103 | 2024 | 68153 | 0.660 |
Why?
| Depression | 8 | 2018 | 1294 | 0.660 |
Why?
| Cardiac Output, Low | 5 | 2006 | 66 | 0.640 |
Why?
| Residence Characteristics | 3 | 2021 | 326 | 0.630 |
Why?
| Primary Health Care | 4 | 2019 | 1668 | 0.620 |
Why?
| Diabetes Mellitus | 9 | 2018 | 999 | 0.590 |
Why?
| Atherosclerosis | 2 | 2019 | 403 | 0.580 |
Why?
| Choice Behavior | 1 | 2019 | 164 | 0.580 |
Why?
| Colorado | 22 | 2021 | 4375 | 0.580 |
Why?
| United States | 44 | 2023 | 13830 | 0.560 |
Why?
| Minority Groups | 3 | 2023 | 251 | 0.550 |
Why?
| Heart Arrest | 2 | 2020 | 310 | 0.530 |
Why?
| Communication | 4 | 2023 | 838 | 0.510 |
Why?
| American Heart Association | 3 | 2018 | 298 | 0.490 |
Why?
| Safety-net Providers | 2 | 2018 | 108 | 0.490 |
Why?
| Cardiopulmonary Resuscitation | 4 | 2024 | 225 | 0.490 |
Why?
| Emergency Service, Hospital | 5 | 2021 | 1901 | 0.480 |
Why?
| Emergency Medical Services | 4 | 2023 | 518 | 0.460 |
Why?
| Health Services Research | 2 | 2015 | 391 | 0.460 |
Why?
| Quality of Health Care | 8 | 2007 | 606 | 0.450 |
Why?
| Delivery of Health Care | 7 | 2023 | 895 | 0.430 |
Why?
| Risk Factors | 26 | 2019 | 9704 | 0.410 |
Why?
| Blood Pressure Determination | 1 | 2014 | 148 | 0.410 |
Why?
| Aged, 80 and over | 29 | 2021 | 7033 | 0.410 |
Why?
| Ventricular Dysfunction, Left | 7 | 2008 | 383 | 0.400 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 758 | 0.390 |
Why?
| Guideline Adherence | 6 | 2021 | 521 | 0.390 |
Why?
| Medically Uninsured | 1 | 2013 | 127 | 0.390 |
Why?
| Surveys and Questionnaires | 11 | 2024 | 5362 | 0.380 |
Why?
| Decision Making | 2 | 2016 | 847 | 0.380 |
Why?
| Adult | 31 | 2024 | 35299 | 0.380 |
Why?
| Patient-Centered Care | 2 | 2016 | 501 | 0.370 |
Why?
| Kidney Diseases | 3 | 2011 | 367 | 0.370 |
Why?
| Blood Pressure Monitoring, Ambulatory | 2 | 2011 | 84 | 0.360 |
Why?
| Physicians, Primary Care | 2 | 2018 | 229 | 0.360 |
Why?
| Decision Support Techniques | 1 | 2015 | 396 | 0.360 |
Why?
| Survival Analysis | 7 | 2010 | 1263 | 0.360 |
Why?
| Carotid Artery Diseases | 1 | 2011 | 64 | 0.360 |
Why?
| Electrocardiography | 4 | 2009 | 604 | 0.350 |
Why?
| Cohort Studies | 26 | 2020 | 5388 | 0.350 |
Why?
| Follow-Up Studies | 17 | 2022 | 4892 | 0.350 |
Why?
| Insurance, Health | 1 | 2013 | 267 | 0.350 |
Why?
| Risk Assessment | 10 | 2019 | 3232 | 0.350 |
Why?
| Practice Patterns, Physicians' | 3 | 2018 | 1258 | 0.340 |
Why?
| Coronary Artery Disease | 3 | 2013 | 678 | 0.340 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 9 | 2008 | 199 | 0.320 |
Why?
| Survival Rate | 13 | 2020 | 1869 | 0.300 |
Why?
| Attitude to Death | 1 | 2008 | 67 | 0.300 |
Why?
| Quality of Life | 12 | 2019 | 2680 | 0.290 |
Why?
| Renin-Angiotensin System | 1 | 2008 | 79 | 0.290 |
Why?
| Proportional Hazards Models | 11 | 2015 | 1196 | 0.290 |
Why?
| Exercise | 2 | 2018 | 1929 | 0.290 |
Why?
| Patient Education as Topic | 4 | 2018 | 737 | 0.280 |
Why?
| Heart Rate | 2 | 2011 | 800 | 0.280 |
Why?
| Medicare | 14 | 2017 | 715 | 0.280 |
Why?
| Atrial Fibrillation | 2 | 2009 | 377 | 0.270 |
Why?
| Stroke | 3 | 2021 | 1063 | 0.270 |
Why?
| Diabetic Angiopathies | 4 | 2009 | 262 | 0.260 |
Why?
| Retrospective Studies | 30 | 2020 | 14454 | 0.260 |
Why?
| Models, Statistical | 2 | 2013 | 621 | 0.260 |
Why?
| Sex Factors | 10 | 2020 | 1945 | 0.250 |
Why?
| Kidney | 3 | 2011 | 1302 | 0.250 |
Why?
| Value of Life | 1 | 2005 | 17 | 0.240 |
Why?
| Prevalence | 7 | 2018 | 2547 | 0.240 |
Why?
| Cross-Sectional Studies | 14 | 2017 | 5039 | 0.240 |
Why?
| Insurance, Health, Reimbursement | 2 | 2017 | 95 | 0.230 |
Why?
| Multivariate Analysis | 10 | 2017 | 1484 | 0.230 |
Why?
| Monitoring, Ambulatory | 1 | 2005 | 83 | 0.230 |
Why?
| Ambulances | 2 | 2023 | 50 | 0.230 |
Why?
| Touch Perception | 1 | 2024 | 15 | 0.220 |
Why?
| Patient Compliance | 4 | 2018 | 560 | 0.220 |
Why?
| Palliative Care | 4 | 2016 | 713 | 0.220 |
Why?
| Prognosis | 9 | 2018 | 3772 | 0.220 |
Why?
| Epidemiologic Studies | 1 | 2004 | 65 | 0.220 |
Why?
| Peer Review, Research | 1 | 2004 | 41 | 0.220 |
Why?
| Young Adult | 9 | 2021 | 12312 | 0.220 |
Why?
| Single-Blind Method | 2 | 2021 | 267 | 0.220 |
Why?
| Nisoldipine | 1 | 2003 | 7 | 0.210 |
Why?
| Enalapril | 1 | 2003 | 16 | 0.210 |
Why?
| Smoking Cessation | 1 | 2007 | 408 | 0.210 |
Why?
| Shock, Traumatic | 1 | 2023 | 14 | 0.210 |
Why?
| Attitude of Health Personnel | 2 | 2012 | 1093 | 0.210 |
Why?
| Pneumonia | 2 | 2019 | 598 | 0.200 |
Why?
| Treatment Outcome | 15 | 2023 | 10151 | 0.200 |
Why?
| Sepsis | 2 | 2019 | 556 | 0.200 |
Why?
| Social Class | 2 | 2019 | 258 | 0.200 |
Why?
| Sexual Behavior | 3 | 2020 | 481 | 0.200 |
Why?
| Delivery of Health Care, Integrated | 1 | 2005 | 248 | 0.190 |
Why?
| Hypoglycemic Agents | 5 | 2012 | 1212 | 0.190 |
Why?
| Mexican Americans | 2 | 2015 | 113 | 0.190 |
Why?
| Prospective Studies | 12 | 2019 | 7036 | 0.190 |
Why?
| Critical Illness | 2 | 2023 | 730 | 0.190 |
Why?
| Communication Barriers | 1 | 2023 | 98 | 0.190 |
Why?
| Intention to Treat Analysis | 1 | 2021 | 68 | 0.190 |
Why?
| Perception | 1 | 2004 | 338 | 0.190 |
Why?
| Acculturation | 2 | 2012 | 50 | 0.180 |
Why?
| Telemedicine | 2 | 2011 | 782 | 0.180 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2017 | 2429 | 0.180 |
Why?
| Glomerular Filtration Rate | 5 | 2011 | 681 | 0.180 |
Why?
| Cardiologists | 2 | 2018 | 45 | 0.180 |
Why?
| Stroke Volume | 7 | 2008 | 586 | 0.180 |
Why?
| Drug Prescriptions | 6 | 2009 | 248 | 0.170 |
Why?
| Brain Ischemia | 2 | 2021 | 305 | 0.170 |
Why?
| Electronic Health Records | 2 | 2018 | 974 | 0.170 |
Why?
| Professional-Patient Relations | 1 | 2021 | 140 | 0.170 |
Why?
| Writing | 1 | 2021 | 91 | 0.170 |
Why?
| Incidence | 6 | 2021 | 2616 | 0.170 |
Why?
| Age Factors | 11 | 2018 | 3103 | 0.170 |
Why?
| Adolescent | 10 | 2020 | 20179 | 0.170 |
Why?
| Chronic Disease | 6 | 2018 | 1705 | 0.160 |
Why?
| Chi-Square Distribution | 5 | 2015 | 511 | 0.160 |
Why?
| Quality Assurance, Health Care | 6 | 2007 | 316 | 0.160 |
Why?
| Cardiology | 3 | 2007 | 260 | 0.160 |
Why?
| Health Care Surveys | 4 | 2019 | 555 | 0.160 |
Why?
| Health Knowledge, Attitudes, Practice | 3 | 2024 | 1275 | 0.160 |
Why?
| Time Factors | 10 | 2015 | 6482 | 0.160 |
Why?
| Fluid Therapy | 1 | 2020 | 134 | 0.150 |
Why?
| Shock | 1 | 2020 | 93 | 0.150 |
Why?
| Public Opinion | 1 | 2019 | 63 | 0.150 |
Why?
| Income | 1 | 2019 | 189 | 0.150 |
Why?
| Formative Feedback | 1 | 2018 | 26 | 0.150 |
Why?
| Patient Selection | 5 | 2009 | 663 | 0.150 |
Why?
| Emergency Treatment | 1 | 2019 | 113 | 0.150 |
Why?
| Medical Audit | 1 | 2018 | 77 | 0.150 |
Why?
| Health Literacy | 2 | 2018 | 161 | 0.150 |
Why?
| Withholding Treatment | 2 | 2016 | 70 | 0.150 |
Why?
| Multilevel Analysis | 1 | 2017 | 27 | 0.150 |
Why?
| Severity of Illness Index | 3 | 2019 | 2721 | 0.140 |
Why?
| Patient Readmission | 5 | 2012 | 664 | 0.140 |
Why?
| Censuses | 1 | 2017 | 27 | 0.140 |
Why?
| Patient Care Team | 2 | 2018 | 605 | 0.140 |
Why?
| California | 1 | 2019 | 398 | 0.140 |
Why?
| Contraception | 1 | 2019 | 151 | 0.140 |
Why?
| Angina Pectoris | 2 | 2008 | 67 | 0.140 |
Why?
| Odds Ratio | 6 | 2018 | 1023 | 0.140 |
Why?
| International Cooperation | 1 | 2018 | 171 | 0.140 |
Why?
| Patient Navigation | 1 | 2019 | 79 | 0.140 |
Why?
| Goals | 1 | 2018 | 160 | 0.140 |
Why?
| Hyperglycemia | 3 | 2010 | 326 | 0.140 |
Why?
| ST Elevation Myocardial Infarction | 1 | 2017 | 52 | 0.140 |
Why?
| Comorbidity | 9 | 2012 | 1543 | 0.140 |
Why?
| Statistics as Topic | 3 | 2008 | 302 | 0.140 |
Why?
| Peer Group | 1 | 2019 | 225 | 0.140 |
Why?
| Qualitative Research | 3 | 2019 | 1226 | 0.130 |
Why?
| Interviews as Topic | 3 | 2015 | 715 | 0.130 |
Why?
| Logistic Models | 9 | 2017 | 1974 | 0.130 |
Why?
| Program Development | 1 | 2018 | 360 | 0.130 |
Why?
| Cell Phone | 1 | 2016 | 70 | 0.130 |
Why?
| Hospital Mortality | 5 | 2019 | 844 | 0.130 |
Why?
| Organizational Case Studies | 1 | 2015 | 75 | 0.130 |
Why?
| Self-Management | 1 | 2018 | 162 | 0.120 |
Why?
| Diuretics | 3 | 2006 | 74 | 0.120 |
Why?
| Weight Reduction Programs | 1 | 2017 | 111 | 0.120 |
Why?
| Registries | 6 | 2020 | 1877 | 0.120 |
Why?
| Urban Population | 1 | 2018 | 440 | 0.120 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 90 | 0.120 |
Why?
| Leadership | 2 | 2018 | 356 | 0.120 |
Why?
| Predictive Value of Tests | 4 | 2010 | 1935 | 0.120 |
Why?
| Xanthines | 2 | 2007 | 17 | 0.120 |
Why?
| Diffusion of Innovation | 1 | 2015 | 96 | 0.120 |
Why?
| Thiazolidinediones | 3 | 2005 | 137 | 0.120 |
Why?
| Renal Dialysis | 1 | 2019 | 417 | 0.120 |
Why?
| Clinical Decision-Making | 1 | 2017 | 304 | 0.120 |
Why?
| Education, Medical | 1 | 2018 | 243 | 0.120 |
Why?
| Organizational Innovation | 1 | 2015 | 138 | 0.120 |
Why?
| Community Health Services | 2 | 2008 | 226 | 0.120 |
Why?
| Exercise Test | 1 | 2017 | 613 | 0.120 |
Why?
| Hypercholesterolemia | 1 | 2015 | 101 | 0.120 |
Why?
| Lipoproteins | 1 | 2015 | 171 | 0.120 |
Why?
| Organizational Culture | 1 | 2015 | 138 | 0.110 |
Why?
| Blood Vessels | 1 | 2016 | 181 | 0.110 |
Why?
| Cultural Competency | 2 | 2013 | 81 | 0.110 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 137 | 0.110 |
Why?
| Acute Coronary Syndrome | 1 | 2017 | 267 | 0.110 |
Why?
| ROC Curve | 2 | 2020 | 500 | 0.110 |
Why?
| Practice Guidelines as Topic | 4 | 2017 | 1478 | 0.110 |
Why?
| Ventricular Function, Left | 4 | 2009 | 524 | 0.110 |
Why?
| Adiponectin | 1 | 2015 | 234 | 0.110 |
Why?
| Cholesterol | 1 | 2015 | 406 | 0.110 |
Why?
| Pilot Projects | 3 | 2015 | 1563 | 0.110 |
Why?
| Creatinine | 5 | 2006 | 475 | 0.100 |
Why?
| Kidney Failure, Chronic | 1 | 2019 | 535 | 0.100 |
Why?
| Aspirin | 3 | 2005 | 376 | 0.100 |
Why?
| Triglycerides | 1 | 2015 | 523 | 0.100 |
Why?
| Disease Management | 3 | 2008 | 587 | 0.100 |
Why?
| Diabetes Complications | 3 | 2009 | 223 | 0.100 |
Why?
| Metformin | 3 | 2005 | 312 | 0.100 |
Why?
| Inpatients | 5 | 2009 | 465 | 0.100 |
Why?
| Kaplan-Meier Estimate | 2 | 2015 | 853 | 0.100 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2005 | 1356 | 0.100 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 413 | 0.090 |
Why?
| Hyperlipidemias | 1 | 2012 | 126 | 0.090 |
Why?
| Trust | 1 | 2012 | 116 | 0.090 |
Why?
| Hospitals, Military | 1 | 2011 | 26 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1815 | 0.090 |
Why?
| Medical Laboratory Science | 1 | 2010 | 9 | 0.090 |
Why?
| Adiposity | 1 | 2015 | 504 | 0.090 |
Why?
| Health Promotion | 1 | 2017 | 716 | 0.090 |
Why?
| Biomedical Research | 2 | 2007 | 635 | 0.090 |
Why?
| Adrenergic beta-Antagonists | 3 | 2008 | 318 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 146 | 0.090 |
Why?
| Vascular Stiffness | 1 | 2015 | 464 | 0.090 |
Why?
| Pregnancy | 2 | 2020 | 6357 | 0.080 |
Why?
| Diet | 2 | 2015 | 1199 | 0.080 |
Why?
| Telephone | 1 | 2011 | 168 | 0.080 |
Why?
| Affect | 1 | 2012 | 285 | 0.080 |
Why?
| Health Status Indicators | 3 | 2008 | 166 | 0.080 |
Why?
| Double-Blind Method | 4 | 2015 | 1848 | 0.080 |
Why?
| Body Mass Index | 2 | 2016 | 2261 | 0.080 |
Why?
| Nutrition Surveys | 2 | 2008 | 261 | 0.080 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2009 | 138 | 0.080 |
Why?
| Captopril | 1 | 2008 | 10 | 0.080 |
Why?
| Obesity | 2 | 2015 | 2858 | 0.080 |
Why?
| Valsartan | 1 | 2008 | 26 | 0.070 |
Why?
| Tetrazoles | 1 | 2008 | 37 | 0.070 |
Why?
| Pharmacists | 1 | 2011 | 261 | 0.070 |
Why?
| Infant, Newborn | 1 | 2019 | 5687 | 0.070 |
Why?
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 33 | 0.070 |
Why?
| Spironolactone | 2 | 2005 | 28 | 0.070 |
Why?
| Spouse Abuse | 1 | 2008 | 37 | 0.070 |
Why?
| Valine | 1 | 2008 | 74 | 0.070 |
Why?
| Spirituality | 1 | 2009 | 80 | 0.070 |
Why?
| Carbazoles | 1 | 2008 | 84 | 0.070 |
Why?
| Longitudinal Studies | 3 | 2011 | 2710 | 0.070 |
Why?
| Adenosine A1 Receptor Antagonists | 1 | 2007 | 2 | 0.070 |
Why?
| Health Surveys | 1 | 2010 | 492 | 0.070 |
Why?
| Linear Models | 4 | 2015 | 813 | 0.070 |
Why?
| Patients | 1 | 2009 | 166 | 0.070 |
Why?
| Propanolamines | 1 | 2008 | 96 | 0.070 |
Why?
| Medical Records Systems, Computerized | 1 | 2008 | 93 | 0.070 |
Why?
| Medically Underserved Area | 1 | 2008 | 83 | 0.070 |
Why?
| Insulin Resistance | 1 | 2015 | 1164 | 0.070 |
Why?
| Social Workers | 2 | 2018 | 39 | 0.070 |
Why?
| Vascular Diseases | 1 | 2009 | 232 | 0.070 |
Why?
| United States Department of Veterans Affairs | 1 | 2011 | 634 | 0.070 |
Why?
| Defibrillators, Implantable | 1 | 2010 | 295 | 0.070 |
Why?
| Self Care | 1 | 2009 | 368 | 0.070 |
Why?
| Blood Urea Nitrogen | 1 | 2006 | 53 | 0.070 |
Why?
| National Health Programs | 1 | 2005 | 17 | 0.060 |
Why?
| Patient Admission | 4 | 2009 | 182 | 0.060 |
Why?
| Diet, Sodium-Restricted | 1 | 2006 | 36 | 0.060 |
Why?
| Internal Medicine | 1 | 2008 | 246 | 0.060 |
Why?
| Coronary Artery Bypass | 2 | 2006 | 221 | 0.060 |
Why?
| Body Temperature | 1 | 2006 | 212 | 0.060 |
Why?
| Dyspnea | 2 | 2018 | 238 | 0.060 |
Why?
| Cost of Illness | 2 | 2004 | 277 | 0.060 |
Why?
| Biomarkers | 6 | 2015 | 3880 | 0.060 |
Why?
| Fatigue | 2 | 2018 | 317 | 0.060 |
Why?
| Edema | 1 | 2006 | 125 | 0.060 |
Why?
| Natriuretic Peptide, Brain | 1 | 2005 | 99 | 0.060 |
Why?
| Patient Discharge | 4 | 2006 | 853 | 0.060 |
Why?
| Interinstitutional Relations | 1 | 2005 | 57 | 0.060 |
Why?
| Health Education | 1 | 2008 | 333 | 0.060 |
Why?
| Self Report | 2 | 2022 | 801 | 0.060 |
Why?
| Hospital Costs | 1 | 2005 | 114 | 0.060 |
Why?
| Terminally Ill | 1 | 2005 | 35 | 0.060 |
Why?
| Nurses | 2 | 2018 | 164 | 0.060 |
Why?
| Asthma | 1 | 2018 | 2213 | 0.060 |
Why?
| Drug Costs | 1 | 2005 | 97 | 0.060 |
Why?
| Cardiac Pacing, Artificial | 1 | 2005 | 84 | 0.060 |
Why?
| Specialization | 1 | 2005 | 145 | 0.060 |
Why?
| Coronary Care Units | 1 | 2004 | 16 | 0.060 |
Why?
| Depressive Disorder | 1 | 2007 | 360 | 0.060 |
Why?
| United Kingdom | 1 | 2005 | 257 | 0.060 |
Why?
| Anemia | 1 | 2005 | 160 | 0.060 |
Why?
| Counseling | 1 | 2007 | 382 | 0.060 |
Why?
| Multicenter Studies as Topic | 1 | 2005 | 285 | 0.060 |
Why?
| Nurse Administrators | 1 | 2004 | 39 | 0.060 |
Why?
| Nurse Practitioners | 1 | 2006 | 127 | 0.060 |
Why?
| Cultural Characteristics | 1 | 2004 | 63 | 0.050 |
Why?
| Medicine | 1 | 2005 | 118 | 0.050 |
Why?
| Patient Reported Outcome Measures | 2 | 2018 | 368 | 0.050 |
Why?
| Internet | 1 | 2008 | 617 | 0.050 |
Why?
| Educational Status | 1 | 2006 | 470 | 0.050 |
Why?
| North America | 1 | 2004 | 289 | 0.050 |
Why?
| Alcohol Drinking | 2 | 2009 | 752 | 0.050 |
Why?
| Ibuprofen | 1 | 2003 | 80 | 0.050 |
Why?
| Vulnerable Populations | 1 | 2004 | 157 | 0.050 |
Why?
| Albuminuria | 1 | 2004 | 181 | 0.050 |
Why?
| Thiazoles | 1 | 2003 | 115 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2003 | 123 | 0.050 |
Why?
| Needs Assessment | 1 | 2005 | 359 | 0.050 |
Why?
| South Africa | 1 | 2023 | 192 | 0.050 |
Why?
| Health Behavior | 2 | 2011 | 741 | 0.050 |
Why?
| Continuity of Patient Care | 1 | 2005 | 275 | 0.050 |
Why?
| Risk Reduction Behavior | 1 | 2004 | 209 | 0.050 |
Why?
| Purinergic P1 Receptor Antagonists | 1 | 2002 | 8 | 0.050 |
Why?
| Diuresis | 1 | 2002 | 9 | 0.050 |
Why?
| Hypertension, Malignant | 1 | 2002 | 2 | 0.050 |
Why?
| Bayes Theorem | 1 | 2004 | 369 | 0.050 |
Why?
| Weight Gain | 1 | 2006 | 503 | 0.050 |
Why?
| Cardiac Tamponade | 1 | 2002 | 13 | 0.050 |
Why?
| Furosemide | 1 | 2002 | 38 | 0.050 |
Why?
| Ambulatory Care | 2 | 2006 | 503 | 0.050 |
Why?
| Cooperative Behavior | 1 | 2005 | 432 | 0.050 |
Why?
| Total Quality Management | 1 | 2002 | 60 | 0.050 |
Why?
| Pain Measurement | 1 | 2004 | 487 | 0.050 |
Why?
| Lupus Nephritis | 1 | 2002 | 49 | 0.050 |
Why?
| Hospice Care | 1 | 2005 | 198 | 0.050 |
Why?
| Health Care Costs | 1 | 2004 | 367 | 0.050 |
Why?
| Health Maintenance Organizations | 2 | 2012 | 99 | 0.040 |
Why?
| Forecasting | 1 | 2002 | 358 | 0.040 |
Why?
| Mortality | 2 | 2018 | 307 | 0.040 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 336 | 0.040 |
Why?
| Algorithms | 1 | 2008 | 1618 | 0.040 |
Why?
| Emergencies | 1 | 2021 | 155 | 0.040 |
Why?
| Contraindications | 3 | 2005 | 88 | 0.040 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2003 | 440 | 0.040 |
Why?
| Confidence Intervals | 2 | 2012 | 316 | 0.040 |
Why?
| Family Practice | 1 | 2004 | 455 | 0.040 |
Why?
| Veterans | 1 | 2011 | 1398 | 0.040 |
Why?
| Risk Adjustment | 1 | 2020 | 79 | 0.040 |
Why?
| Coronary Disease | 1 | 2002 | 382 | 0.040 |
Why?
| Blood Glucose | 2 | 2009 | 2093 | 0.040 |
Why?
| Area Under Curve | 1 | 2020 | 279 | 0.040 |
Why?
| Electric Countershock | 1 | 2019 | 104 | 0.040 |
Why?
| Sexuality | 1 | 2019 | 30 | 0.040 |
Why?
| Research | 2 | 2018 | 411 | 0.040 |
Why?
| Geographic Mapping | 1 | 2018 | 20 | 0.040 |
Why?
| Length of Stay | 2 | 2017 | 1113 | 0.040 |
Why?
| Hospitals | 1 | 2003 | 631 | 0.040 |
Why?
| Program Evaluation | 2 | 2018 | 874 | 0.040 |
Why?
| Zimbabwe | 1 | 2018 | 54 | 0.040 |
Why?
| Palliative Medicine | 1 | 2018 | 15 | 0.040 |
Why?
| Alcoholism | 1 | 2004 | 766 | 0.040 |
Why?
| Patient Health Questionnaire | 1 | 2018 | 36 | 0.040 |
Why?
| Resuscitation | 1 | 2020 | 234 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2011 | 1204 | 0.040 |
Why?
| Capacity Building | 1 | 2018 | 59 | 0.040 |
Why?
| Cholesterol, LDL | 2 | 2012 | 360 | 0.030 |
Why?
| Anxiety | 2 | 2018 | 954 | 0.030 |
Why?
| Time-to-Treatment | 1 | 2018 | 179 | 0.030 |
Why?
| Secondary Prevention | 1 | 2018 | 219 | 0.030 |
Why?
| Analysis of Variance | 1 | 2020 | 1269 | 0.030 |
Why?
| Emotional Adjustment | 1 | 2016 | 16 | 0.030 |
Why?
| Sex Distribution | 1 | 2017 | 358 | 0.030 |
Why?
| Peer Review | 2 | 2007 | 47 | 0.030 |
Why?
| Primary Prevention | 1 | 2018 | 185 | 0.030 |
Why?
| Sex Offenses | 1 | 2019 | 178 | 0.030 |
Why?
| Emergency Medicine | 1 | 2018 | 216 | 0.030 |
Why?
| Diet Surveys | 1 | 2015 | 92 | 0.030 |
Why?
| Population Surveillance | 1 | 2018 | 427 | 0.030 |
Why?
| Respiration, Artificial | 1 | 2020 | 598 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 91 | 0.030 |
Why?
| Insurance Coverage | 1 | 2017 | 220 | 0.030 |
Why?
| Canada | 2 | 2006 | 344 | 0.030 |
Why?
| Motivation | 1 | 2020 | 546 | 0.030 |
Why?
| Feasibility Studies | 1 | 2019 | 860 | 0.030 |
Why?
| Medical Records | 2 | 2006 | 170 | 0.030 |
Why?
| Healthy Volunteers | 1 | 2015 | 202 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2016 | 248 | 0.030 |
Why?
| Neoplasms | 1 | 2009 | 2464 | 0.030 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2002 | 945 | 0.030 |
Why?
| Mineralocorticoid Receptor Antagonists | 2 | 2005 | 45 | 0.030 |
Why?
| Language | 1 | 2017 | 281 | 0.030 |
Why?
| Regression Analysis | 2 | 2009 | 978 | 0.030 |
Why?
| Administration, Oral | 2 | 2007 | 754 | 0.030 |
Why?
| Consensus | 2 | 2007 | 613 | 0.030 |
Why?
| Pain Management | 1 | 2016 | 318 | 0.030 |
Why?
| Stereotyped Behavior | 1 | 2012 | 19 | 0.030 |
Why?
| Aging | 1 | 2003 | 1750 | 0.030 |
Why?
| Up-Regulation | 1 | 2015 | 825 | 0.020 |
Why?
| Quality Indicators, Health Care | 2 | 2006 | 296 | 0.020 |
Why?
| Pain | 1 | 2018 | 757 | 0.020 |
Why?
| Disease Progression | 2 | 2011 | 2602 | 0.020 |
Why?
| Cardiac Resynchronization Therapy | 1 | 2012 | 45 | 0.020 |
Why?
| Culture | 1 | 2012 | 123 | 0.020 |
Why?
| Speech Recognition Software | 1 | 2010 | 11 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2007 | 1936 | 0.020 |
Why?
| Cause of Death | 1 | 2012 | 393 | 0.020 |
Why?
| User-Computer Interface | 1 | 2010 | 147 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 60 | 0.020 |
Why?
| Medication Therapy Management | 1 | 2010 | 74 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 1663 | 0.020 |
Why?
| Hospitals, University | 1 | 2008 | 176 | 0.020 |
Why?
| Natriuresis | 1 | 2007 | 11 | 0.020 |
Why?
| Kidney Function Tests | 1 | 2007 | 145 | 0.020 |
Why?
| Ontario | 1 | 2006 | 89 | 0.020 |
Why?
| Risk | 1 | 2009 | 853 | 0.020 |
Why?
| Patient Participation | 1 | 2010 | 410 | 0.020 |
Why?
| Pravastatin | 1 | 2006 | 26 | 0.020 |
Why?
| Sleep Wake Disorders | 1 | 2009 | 250 | 0.020 |
Why?
| Lovastatin | 1 | 2006 | 27 | 0.020 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2006 | 51 | 0.020 |
Why?
| Heptanoic Acids | 1 | 2006 | 62 | 0.020 |
Why?
| Databases as Topic | 1 | 2005 | 59 | 0.020 |
Why?
| Hematocrit | 1 | 2005 | 93 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2007 | 751 | 0.020 |
Why?
| Cognition Disorders | 1 | 2009 | 497 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2005 | 112 | 0.010 |
Why?
| Hospitals, Urban | 1 | 2005 | 128 | 0.010 |
Why?
| Family | 1 | 2009 | 651 | 0.010 |
Why?
| Midwestern United States | 1 | 2004 | 40 | 0.010 |
Why?
| Northwestern United States | 1 | 2004 | 55 | 0.010 |
Why?
| Pyrroles | 1 | 2006 | 191 | 0.010 |
Why?
| Potassium | 1 | 2005 | 137 | 0.010 |
Why?
| Age Distribution | 1 | 2005 | 371 | 0.010 |
Why?
| Hospitals, Municipal | 1 | 2004 | 1 | 0.010 |
Why?
| Myocardial Revascularization | 1 | 2004 | 69 | 0.010 |
Why?
| Cognition | 1 | 2012 | 1107 | 0.010 |
Why?
| Disease-Free Survival | 1 | 2006 | 647 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1460 | 0.010 |
Why?
| Anti-Arrhythmia Agents | 1 | 2004 | 110 | 0.010 |
Why?
| Drug Utilization | 1 | 2004 | 166 | 0.010 |
Why?
| Drug Utilization Review | 1 | 2003 | 56 | 0.010 |
Why?
| Indoles | 1 | 2006 | 371 | 0.010 |
Why?
| Fee-for-Service Plans | 1 | 2003 | 88 | 0.010 |
Why?
| Cardiotonic Agents | 1 | 2003 | 124 | 0.010 |
Why?
| Arrhythmias, Cardiac | 1 | 2005 | 316 | 0.010 |
Why?
| Drug Interactions | 1 | 2003 | 357 | 0.010 |
Why?
| Pyridines | 1 | 2006 | 475 | 0.010 |
Why?
| Overweight | 1 | 2006 | 524 | 0.010 |
Why?
| Electrolytes | 1 | 2002 | 58 | 0.010 |
Why?
| Urinalysis | 1 | 2002 | 69 | 0.010 |
Why?
| Cardiac Catheterization | 1 | 2004 | 515 | 0.010 |
Why?
| Sodium | 1 | 2002 | 205 | 0.010 |
Why?
| Drug Combinations | 1 | 2002 | 323 | 0.010 |
Why?
| Morbidity | 1 | 2002 | 301 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2003 | 1009 | 0.010 |
Why?
| Diabetic Nephropathies | 1 | 2004 | 278 | 0.010 |
Why?
| Referral and Consultation | 1 | 2005 | 727 | 0.010 |
Why?
| Heart Ventricles | 1 | 2005 | 765 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2002 | 513 | 0.010 |
Why?
| Recovery of Function | 1 | 2003 | 641 | 0.010 |
Why?
| Mental Disorders | 1 | 2008 | 1027 | 0.010 |
Why?
| Substance-Related Disorders | 1 | 2008 | 1013 | 0.010 |
Why?
| Case-Control Studies | 1 | 2005 | 3328 | 0.010 |
Why?
| Hemodynamics | 1 | 2002 | 1081 | 0.010 |
Why?
| Internship and Residency | 1 | 2004 | 1048 | 0.010 |
Why?
|
|
Havranek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|